Background The incidence of coronary perforation using new percutaneous revascularization techniques may be increased compared with PTCA. Still, perforation is uncommonly reported, and the optimal management and expected outcome remain unknown. The objectives of the study were to determine the incidence of coronary perforation using balloon angioplasty (percutaneous transluminal coronary angioplasty, PTCA) and new revascularization techniques and to develop optimal strategies for its management based on classification and outcome.
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Methods and Results Eleven sites with frequent use of new revascularization devices and prospective coding of consecutive procedures for coronary perforation during 1990 to 1991 contributed to a perforation registry. Patients with perforation were matched by device with an equal-sized cohort without perforation. Data were collected centrally, and all procedural cineangiograms were reviewed at a core angiographic laboratory. A classification scheme based on angiographic appearance of the perforation (I, extraluminal crater without extravasation; II, pericardial or myocardial blushing; III, perforation 21-mm diameter with contrast streaming; and cavity spilling) was evaluated as a predictor of outcome and as a basis for management. Perforation was observed in 62 of 12 900 procedures reported (0.5%; 95% confidence interval, 0.4% to 0.6%), more commonly with devices intended to remove or ablate tissue C oronary perforation with percutaneous transluminal coronary angioplasty (PTCA) occurs only very rarely.1-5 However, with the recent availability of alternative devices that cut, tear, or ablate in order to improve luminal dimensions, perforations have been noted more frequently. [6] [7] [8] The purpose of this registry is to gain information about the frequency of perforation during coronary intervention in the 1990s and to collect information to facilitate a rationale management of this problem.
(atherectomy, laser) than with PTCA (1.3%, 0.9% to 1.6% versus 0.1%, 0.1% to 0.1%; P<.001). The perforation population was notable for its advanced age (67+10 years) and high incidence of female sex (46%) (both P<.001 compared with patients without perforation). Perforation could be treated expectantly or with PTCA but without cardiac surgery in 85%, 90%, and 44% of class I, II, and III perforations, respectively. Class I perforations (n=13, 21%) were associated with death in none, myocardial infarction in none, and tamponade in 8%. The incidences of these adverse events were 0%, 14%, and 13% in class II perforations (n=31, 50%) and 19%, 50%, and 63% in non-cavity spilling class III perforations, respectively (n=16, 26%). Two of the 15 instances of cardiac tamponade (13%) were delayed, occurring within 24 hours after dismissal from the catheterization laboratory.
Conclusions 
Clinical Outcome Variables
The following variables describing in-hospital outcome were obtained from the contributing centers: cardiac tamponade, death, elective coronary artery bypass surgery, duration of balloon inflation (when angioplasty was used as treatment for the perforation), emergency coronary artery bypass surgery, myocardial infarction (creatine kinase .2 upper limit of normal with MB fraction >5%), maximum creatine kinase level after treatment, Q-wave myocardial infarction, and treatment of the perforation with balloon angioplasty.
Statistical Analysis
All data were entered into the Perforation Registry Database at the Cleveland Clinic Foundation. Data are expressed as meanti SD unless otherwise indicated. For comparison of paired data, dependent t test analyses were used. For nonpaired data, x' analyses were used to test differences in categorical variables, and ANOVA techniques were used to test differences in continuous variables. Analyses were performed using SYSTAT software (System for Statistics, version 5.01, 1990).
Results

Incidence of Perforation
The incidence and classification of perforations for each device are enumerated in Table 2 . Although differences in patients treated and in device operators make device comparisons somewhat difficult to interpret, it appears that laser ablation and rotational or extraction atherectomies have a somewhat higher incidence of perforation than does directional atherectomy and that all have a greater incidence than is seen with balloon angioplasty.
Baseline Demographics
Clinical characteristics of the patients with and without perforation are shown in Table 3 . Women and the results from guide wire trauma, balloon rupture, or balloon oversizing.1-5 As experience accrues with a number of devices designed to overcome some of the limitations of PTCA that cut, abrade, or ablate tissue, it appears that these may be associated with a higher incidence of this complication,6-8 although the clinical question has not been studied systematically. This increased incidence of perforation is perhaps not surprising due to their limited capacity for directional guidance and tissue removing as opposed to displacing the mechanism of action.
In this multicenter report, we collected information from procedures performed on almost 13 000 patients during 1990 to 1991 from centers using a variety of new devices and that prospectively recorded the occurrence of coronary perforation. The incidence of angiographically apparent perforation by device ranged from 0.1% to 2.1% and was appreciably greater with devices that remove rather than displace tissue (P<.0001). Furthermore, we prospectively tested a classification scheme (Table 1) designed to predict the likelihood of major complications and thus assist the interventionalist in determining the expediency of coronary bypass surgery and the duration during which the patient with a perforation is at risk of abruptly developing cardiac tamponade.
Class I (fully contained) perforations rarely developed tamponade or resulted in ischemia. These may be very difficult or impossible to distinguish angiographically from localized dissections.
Class II (limited extravasation) perforations, when treated with prolonged balloon inflation, usually have a lessening of contrast extravasation and so treated also have a low incidence of adverse sequelae. In both class I and II perforations, anticoagulation with aspirin and 
Summary
Coronary perforation occurs more commonly with new coronary treatment devices that cut, abrade, or ablate as compared with balloon angioplasty and in women and the elderly, but the incidence of this complication with these new devices is low (1% to 2%). Perforations may be classified as to their risk of major complications such as tamponade, and such a classification scheme may help in the management of patients with perforation such that they receive optimal care.
